Full Press Release Details
ADVISORY, Dec. 14, 2007 (PRIME NEWSWIRE) --
Marc Oczachowski, CEO of EDAP TMS S.A. (EDAP), will preside over the
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
Monday, December 17, 2007 at 4:00 p.m. ET
Blandine Confort, Corporate Legal Affairs
011 +33 472153172; blandine.confort@edap-tms.com
Matt Kreps, Investor Relations
469-362-5960; matt@magnoliair.com
Jolene Libretto; 646.441.5220; Jolene.Libretto@nasdaq.com
The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.
An audio transmission of the closing bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Waterfront fiber 1623 as well.
A live Webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About EDAP TMS S.A. (EDAP):
EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically proven choice for High Intensity Focused Ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is a treatment for patients with newly diagnosed localized prostate cancer or who have failed radiotherapy treatment. The company is also developing this technology for the potential treatment of certain other types of tumors. EDAP TMS S.A. also produces and commercializes medical equipment for treatment of urinary tract stones using Extra-corporeal Shockwave Lithotripsy (ESWL).